Skip to main content

Table 1 Patient characteristics

From: SIP SMART: a parallel group randomised feasibility trial of a tailored pre-treatment swallowing intervention package compared with usual care for patients with head and neck cancer

Participant demographics

Intervention group (n = 16)

Care as usual group (n = 16)

Age mean (SD)

58.56 (12.41)

55.19 (9.45)

Gender n (%)

 Male

15 (94%)

12 (75%)

 Female

1 (6%)

4 (25%)

Ethnicity n (%)

 White

11 (69%)

12 (75%)

 Asian/Asian British

3 (19%)

1 (6%)

 Black/ Black British

0 (0%)

1 (6%)

 Chinese

2 (12%)

0 (0%)

 Other

0 (0%)

2 (13%)

Marital status n (%)

 Married

4 (25%)

10 (63%)

 Single/separated

5 (31%)

5 (31%)

 Widowed

1 (6%)

0 (0%)

 Co-habiting

2 (13%)

1 (6.%)

 Divorced

4 (25%)

0 (0%)

Employment status n (%)

 Full-time

7 (44%)

1 (6%)

 Part-time

3 (19%)

1 (6%)

 Self-employed

1 (6%)

5 (31%)

 Not employed

3 (19%)

6 (38%)

 Retired

2 (12%)

3 (19%)

Occupation n (%)

 Manager/director

2 (13%)

1 (6%)

 Graduate professional

4 (25%)

0 (0%)

 Associate professional/technical

1 (6%)

0 (0%)

 Admin/secretarial

1 (6%)

2 (13%)

 Skilled trade

2 (13%)

5 (31%)

 Sales/customer services

1 (6%)

1 (6%)

 Caring/leisure

4 (25%)

6 (38%)

 Other

1 (6%)

1 (6%)

AJCC numeric tumour stage

  

 III

6 (37.5%)

6 (37.5%)

 IV

10 (62.5%)

10 (62.5%)

Tumour site n (%)

 Oral cavity

5 (31%)

3 (19%)

 Nasopharynx

1 (6%)

0 (0%)

 Oropharynx

9 (56%)

10 (62%)

 Hypopharynx/larynx

1 (6%)

3 (19%)

Cancer treatment n (%)

 Surgery

1 (6%)

0 (0%)

 Radiotherapy

4 (25%)

1 (6.%)

 Surgery & radiotherapy

1 (6%)

2 (12%)

 Radiotherapy & chemotherapy

9 (56%)

11 (69%)

 All three

1 (6%)

2 (13%)

Other treatment n (%)

 Nasogastric tube

4 (25%)

4 (25%)

 Gastrostomy tube

10 (62%)

11 (69%)

 Neither/NA

2 (13%)

1 (6%)

 Weight Baseline mean (SD)

72.46 (15.37)

78.46 (15.36)

 BMI Baseline mean (SD)

24.71 (3.77)

27.14 (4.19)